Ovarian Cancer is the seventh most common cancer in women. Each year, around 200,000 new cases are diagnosed.

In United States 22,500 women are diagnosed and 14,240 die every year.

Epithelial Ovary Cancer (EOC) is one of the most aggressive forms of cancer, and accounts for 80% of all ovarian cancers due to high metastatic rates at presentation.

Almost 85% of EOC patients, present metastatic disease at diagnosis.

At  present, no effective treatment is available for advance stages (stage IV) of the disease, with five year survival rates that are below 20%.